Home | Business News | Browse by Publication | P | PR Newswire

Idenix Pharmaceuticals Completes Enrollment of Valopicitabine (NM283) Phase IIb Trial in Treatment Refractory Hepatitis C Genotype 1 Patients.

Publication: PR Newswire
Publication Date: 31-MAY-05
Format: Online
Delivery: Immediate Online Access

Article Excerpt
- First Hepatitis C Antiviral Drug to Reach This Stage of Development -

CAMBRIDGE, Mass., May 31 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. , a biopharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of human viral and other infectious diseases, today announced that it has completed enrollment of its phase IIb clinical trial of valopicitabine (NM283) with more than 170 treatment refractory hepatitis C genotype 1 patients. The company believes that this is the first time a direct antiviral drug has reached this stage of clinical testing for this patient population.

"Today, there are very limited treatment options for treatment refractory hepatitis C patients, or patients that have failed prior treatment with existing hepatitis C therapies. Among this patient population, approximately 10 percent respond to retreatment with the current standard of care, pegylated interferon plus ribavirin," said Jean-Pierre Sommadossi, Ph.D.,...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
LivePerson to Showcase Industry Solutions at Internet Retailer 2005 Co..., May 31, 2005
Raytheon Features Integrated Mission Solutions for a Net-Enabled World..., May 31, 2005
Patni Computer Systems Strengthens Financial Services Executive Team., May 31, 2005
Competitive Athlete Training Zone (CATZ) to Create a National Franchis..., May 31, 2005
Dynamic Mutual Funds Becomes First Investment Company to Sign for ADP'..., May 31, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.